Archive: 14/11/2018
Drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies
A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called tagraxofusp has demonstrated high response rates in patients with blastic plasmacytoid ...
Nov 14, 2018
Patient-oriented research: A collection featuring benefits, challenges and experiences
Does engaging patients in research projects improve health? A comprehensive collection of 17 innovative demonstration projects—from youth involvement in mental health services to suicide prevention, Indigenous health, children ...
Nov 14, 2018
Cardiogenic shock ups mortality in takotsubo syndrome
(HealthDay)—For patients with takotsubo syndrome (TTS), those with cardiogenic shock (CS) have an increased risk for mortality, according to a research letter published online Nov. 10 in Circulation to coincide with the ...
Nov 14, 2018